Sandoz Group reported higher sales for the second quarter, driven by a strong performance in its biosimilar segment and a return to growth in generics.
Source link
Sandoz Shares Climb After Biosimilar Sales Drive Growth
Date:
More like thisRelated
Hong Kong’s Joshua Wong is spending years of his adult life in prison
HONG KONG -- Some 15 years ago, then-high school...
U.S. Natural Gas Futures Rise for Second Session
U.S. natural gas futures posted back-to-back gains, rising 2.2%...
Elderly man dies after being hit by vehicle in SE Albuquerque
Digital Assignment EditorAPD’s Fatal Crash Unit is investigating a...